Law360 covered Steptoe's Federal Circuit success for Aquestive in an article titled "Split Fed. Circ. Backs PTAB Order Junking IPRs On Remand." On August 29, the Federal Circuit dismissed BioDelivery Sciences' appeal of the Patent Trial and Appeal Board's (PTAB) decision denying inter partes review of Aquestive Therapeutics' patent on a dissolving drug delivery film. The board's ruling came on remand from the appeals court, which held last year that the PTAB erred by upholding the patent without considering all of BioDelivery's invalidity arguments.
Steptoe intellectual property partner John Abramic represents Aquestive along with associates Kate Cappaert and Jamie Lucia. Abramic is based in Steptoe's Chicago office while Cappaert and Lucia are based in the firm's Washington and San Francisco offices respectively.
The full article can be read at Law360 (subscription required).